Nasso Giuseppe, Coppola Roberto, Bonifazi Raffaele, Piancone Felice, Bozzetti Giuseppe, Speziale Giuseppe
Division of Cardiac Surgery, Anthea Hospital, Bari, Italy.
J Thorac Cardiovasc Surg. 2009 May;137(5):1093-100. doi: 10.1016/j.jtcvs.2008.10.029. Epub 2009 Feb 7.
It is unclear (1) whether the use of 2 arterial conduits rather than a single conduit in multivessel coronary artery bypass grafting significantly improves results despite the concomitant use of saphenous vein grafts and (2) whether any among different configurations of composite grafts (left/right thoracic arteries and radial artery) offers an advantage over the others.
Eight hundred fifteen patients were randomized to one of 3 different strategies of revascularization by using the left thoracic artery plus the right thoracic artery or using the left thoracic artery plus the radial artery. Venous grafts were used for the remaining targets. Patients randomized to receive 1 arterial graft served as control subjects. Operative mortality and morbidity were comparable among groups.
The rate of cerebrovascular complications was not statistically lower among patients receiving 2 arterial grafts. At 2 years, overall survival was not significantly different among groups (P = .59). Cardiac event-free survival was significantly better in patients receiving 2 arterial grafts versus control subjects (P < .0001), even among elderly patients (P = .022). The 3 investigated strategies using 2 arterial conduits were similar concerning early and midterm results.
Revascularization with 2 arterial conduits offers better midterm event-free survival than a single arterial graft, irrespective of which second-choice arterial conduit is used (radial artery or right thoracic artery), the simultaneous use of saphenous vein grafts, and the patient's age.
尚不清楚(1)在多支冠状动脉搭桥术中使用2根动脉移植物而非1根动脉移植物,尽管同时使用了大隐静脉移植物,是否能显著改善手术效果;以及(2)复合移植物(左/右胸廓内动脉和桡动脉)的不同配置中,是否有任何一种比其他配置更具优势。
815例患者被随机分为3种不同的血运重建策略之一,即使用左胸廓内动脉加右胸廓内动脉,或使用左胸廓内动脉加桡动脉。其余目标血管使用静脉移植物。随机接受1根动脉移植物的患者作为对照。各组间手术死亡率和发病率相当。
接受2根动脉移植物的患者脑血管并发症发生率在统计学上并无更低。2年时,各组间总生存率无显著差异(P = 0.59)。接受2根动脉移植物的患者无心脏事件生存率显著优于对照组(P < 0.0001),老年患者中也是如此(P = 0.022)。3种使用2根动脉移植物的研究策略在早期和中期结果方面相似。
使用2根动脉移植物进行血运重建比单根动脉移植物具有更好的中期无事件生存率,无论使用的第二选择动脉移植物是桡动脉还是右胸廓内动脉,是否同时使用大隐静脉移植物,以及患者年龄如何。